Orris

What is abdominal girth ratio look like

Reading File
Searching Images

abdominal girth measurement waist circumference ratio

<table><thead><tr><th>Adverse Effects</th><th>Associated ARVs</th><th>Onset/Clinical Manifestations</th><th>Estimated Frequency</th><th>Risk Factors</th><th>Prevention/Monitoring</th><th>Management</th></tr></thead><tbody><tr><td>Lipodystrophy (Fat Maldistribution) General Information</td><td>See below for specific associations.</td><td>Onset • Increase in trunk and limb fat is the first sign; peripheral fat wasting may not appear for 12–24 months after ART initiation.</td><td>Frequency is low (<5%) with current regimens.</td><td>• Genetic predisposition • Puberty • HIV-associated inflammation • Older age • Longer duration of ART • Body habitus</td><td>Prevention • Initiate a calorically appropriate low-fat diet and an exercise regimen. Monitoring • BMI measurement • Waist circumference and waist-hip ratio</td><td>• Physicians should perform a regimen review and consider changing the regimen when lipodystrophy occurs. • Improvement in fat maldistribution can vary following a regimen change. Improvement may occur after several months or years, or it may not occur at all.</td></tr><tr><td>Central Lipohypertrophy or Lipo-accumulation</td><td>Can occur in the absence of ART, but these conditions most often are associated with the use of PIs and EFV.</td><td>Presentation • Central fat accumulation with increased abdominal girth, which may include a dorsocervical fat pad (buffalo hump). Gynecomastia may occur in males, or breast hypertrophy may occur in females, particularly with the use of EFV.</td><td>Frequency is low (<5%) with current regimens.</td><td>• Obesity before initiation of therapy • Sedentary lifestyle</td><td>Prevention • Initiate a calorically appropriate low-fat diet and an exercise regimen. Monitoring • BMI measurement • Waist circumference and waist-hip ratio measurements</td><td>• Counsel patient on lifestyle modification and dietary interventions (e.g., maintaining a calorically appropriate diet that is low in saturated fats and simple carbohydrates and starting an exercise regimen, especially strength training). • Recommend smoking cessation (if applicable) to decrease future CVD risk.</td></tr></tbody></table>

<table><thead><tr><th>Adverse Effects</th><th>Associated ARVs</th><th>Onset/Clinical Manifestations</th><th>Estimated Frequency</th><th>Risk Factors</th><th>Prevention/Monitoring</th><th>Management</th></tr></thead><tbody><tr><td>Lipodystrophy (Fat Maldistribution) General Information</td><td>See below for specific associations.</td><td>Onset • Increase in trunk and limb fat is the first sign; peripheral fat wasting may not appear for 12–24 months after ART initiation.</td><td>Frequency is low (<5%) with current regimens.</td><td>• Genetic predisposition • Puberty • HIV-associated inflammation • Older age • Longer duration of ART • Body habitus</td><td>Prevention • Initiate a calorically appropriate low-fat diet and an exercise regimen. Monitoring • BMI measurement • Waist circumference and waist-hip ratio</td><td>• Physicians should perform a regimen review and consider changing the regimen when lipodystrophy occurs. • Improvement in fat maldistribution can vary following a regimen change. Improvement may occur after several months or years, or it may not occur at all.</td></tr><tr><td>Central Lipohypertrophy or Lipo-accumulation</td><td>Can occur in the absence of ART, but these conditions most often are associated with the use of PIs and EFV.</td><td>Presentation • Central fat accumulation with increased abdominal girth, which may include a dorsocervical fat pad (buffalo hump). Gynecomastia may occur in males, or breast hypertrophy may occur in females, particularly with the use of EFV.</td><td>Frequency is low (<5%) with current regimens.</td><td>• Obesity before initiation of therapy • Sedentary lifestyle</td><td>Prevention • Initiate a calorically appropriate low-fat diet and an exercise regimen. Monitoring • BMI measurement • Waist circumference and waist-hip ratio measurements</td><td>• Counsel patient on lifestyle modification and dietary interventions (e.g., maintaining a calorically appropriate diet that is low in saturated fats and simple carbohydrates and starting an exercise regimen, especially strength training). • Recommend smoking cessation (if applicable) to decrease future CVD risk.</td></tr></tbody></table>

Finding Sources
Searching Images

waist to height ratio obesity measurement diagram

Searching the Web

abdominal girth ratio measurement what does it look like visual

Loading Image
Loading Image
Loading Image
Finding Sources
Reading File
Here is a complete picture of the abdominal girth ratio - what it is, how it looks, and what the numbers mean:

Abdominal Girth (Waist Circumference) - What It Looks Like

The measurement is made by placing a soft tape measure around the bare abdomen at the level of the iliac crest (hip bone) while the person stands upright. The tape should be snug but not compressing the skin. You breathe out naturally - do not suck in - then read the measurement.
Abdominal girth measurement - tape measure placed horizontally around the waist
The image above shows exactly how a clinician measures abdominal girth: a tape is wrapped horizontally around the narrowest part of the abdomen, roughly level with the belly button/iliac crest.

The Two Main Ratios

1. Waist-to-Hip Ratio (WHR)

The waist circumference is divided by the hip circumference (measured at the widest point of the buttocks).
Formula: WHR = Waist (cm) / Hip (cm)
CategoryMenWomen
Average normal~0.93 (range 0.75-1.10)~0.83 (range 0.70-1.00)
Abdominal obesity (WHO)> 0.90> 0.85

2. Waist-to-Height Ratio (WHtR)

The waist circumference is divided by total height.
Formula: WHtR = Waist (cm) / Height (cm)
ResultInterpretation
< 0.5Healthy range
0.51 - 0.59Increased health risk
≥ 0.60High health risk
The NHS rule of thumb: your waist should be less than half your height (ratio < 0.5).

High-Risk Waist Circumference Cutoffs

These thresholds (used in metabolic syndrome criteria) signal abdominal obesity even without a ratio calculation:
  • Men: > 102 cm (40 inches)
  • Women: > 88 cm (35 inches)
(Source: Basic Medical Biochemistry - A Clinical Approach, 6e; Guyton and Hall Textbook of Medical Physiology)

Why It Matters

Abdominal (central) fat - called visceral fat - sits around internal organs and is metabolically active. Elevated abdominal girth is linked to:
  • Metabolic syndrome (with hypertension, high fasting glucose, low HDL, high triglycerides)
  • Type 2 diabetes
  • Cardiovascular disease
  • GERD (increased intra-abdominal pressure reduces lower esophageal sphincter tone)
  • Obstructive sleep apnea and asthma in obese individuals
The waist circumference often correlates better with intra-abdominal (visceral) fat and associated risk than BMI alone, which is why it is recommended as a clinical "vital sign" by major guidelines.
Here is an NHS video walkthrough on how to perform the measurement and calculate the ratio:
https://www.youtube.com/watch?v=dwk8sVCKuio

What about 74-75 -78. As in like above umbilicus-umbilicus-below umbilicus

Finding Sources
Searching the Web

abdominal girth measurement above at below umbilicus three level clinical significance

Great question - this is a three-level abdominal girth assessment, which gives much more clinical detail than a single measurement. Here is how to interpret your numbers:

Your Three-Level Readings

LevelMeasurementWhat it reflects
Above umbilicus74 cmUpper abdominal / epigastric girth
At umbilicus75 cmMid-abdominal girth (closest to standard waist measurement)
Below umbilicus78 cmLower abdominal / hypogastric girth

What This Pattern Means

Your below-umbilicus measurement is the largest (78 cm), with a gradual taper going upward. This is called a lower abdominal predominance or infra-umbilical fullness pattern. Clinically, this can indicate:
  1. Subcutaneous fat accumulation in the lower abdomen - very common, especially in women (gynoid/pear-shaped distribution)
  2. Pelvic organ fullness - e.g., a full bladder, uterine enlargement, ovarian cysts, or a gravid uterus can push the lower abdominal girth out
  3. Ascites - free fluid in the abdomen tends to sag to dependent areas (flanks and lower abdomen when standing), making the below-umbilical girth largest. The classic "flanks bulge" sign
  4. Bowel distension - gas or fecal loading preferentially distends the lower bowel (sigmoid, cecum)
  5. Post-surgical changes - lower midline scars can alter fat distribution

Compare to Visceral (Central) Fat Pattern

If the umbilical level were the largest, that would be more classic for visceral/central obesity - the "apple" shape strongly linked to metabolic syndrome, where intra-abdominal fat pushes outward most at the mid-abdomen.
Your pattern (74-75-78) shows only a 4 cm difference across all three levels, so the abdomen is fairly uniform - the slight infra-umbilical prominence is mild.

Are These Values Normal?

For context, using standard waist circumference cutoffs (measured at the iliac crest, approximately at or just below the umbilicus):
SexLow riskHigh risk
Women< 80 cm≥ 88 cm
Men< 94 cm≥ 102 cm
At 78 cm, this is in the healthy-to-borderline range for women and well within normal for men - no metabolic risk flag by standard cutoffs.

Clinical Use of Three-Level Measurement

Clinicians measure at three levels (above, at, and below the umbilicus) primarily in the following contexts:
  • Monitoring ascites - serial measurements track fluid accumulation or response to diuretics
  • Pregnancy monitoring - tracking abdominal growth
  • Post-operative bowel distension - tracking ileus resolution
  • Abdominal mass surveillance - noting where the girth is increasing can guide where a mass is growing
In routine obesity/metabolic screening, only the single umbilical or iliac crest level is used. The three-level approach is more of a clinical examination or serial monitoring tool.
This is a shared conversation. Sign in to Orris to start your own chat.